COVID-19 ICT (AI, Big Data, Deep Learning, Homecare IT, Contact Tracing, E-Health, Blockchain Technologies, PACS, Teleradiology, Other ICT) Market Boom. Up To $68 Billion* per Annum

WASHINGTON, June 29, 2020 /PRNewswire/ — HSRC announces the publication of its research report, COVID-19 ICT (AI, Big Data, Deep Learning, Homecare IT, Contact Tracing, E-Health, Blockchain, PACS, Teleradiology) Market – 2020-2024. According to the report, the booming COVID-19 related ICT market will reach $68 billion per annum.

The expanding embracement of voice, video and textual communicating platforms in the pandemic inflicted healthcare ecosystem created a substantial promise for the growth of the ICT-based industries.  The COVID-19 Pandemic Mitigation Products Market – 2020-2024 report contains several developments in the ICT field that have transpired since the pandemic emerged.

The COVID-19 pandemic has led to a dramatic growth of all the digital health sectors – from COVID-19 related artificial intelligence to pandemic contact tracing, from homecare IT to pandemic related big data & deep learning technologies. Once the pandemic is eradicated, the public will not understand why we had to visit our G.P. or ER for all our clinical needs. Diagnosticians will benefit from advancements in AI, big data & deep learning technologies. Healthcare CFOs will be delighted by the cost savings to their thinly stretched funded medical facilities, and you, if you belong to the ICT vendors industry, will see growing business opportunities in medical ICT. A growth which will compensate for the 6 months (since the COVID-19 emerged) 4%-5% decline of the global IT markets.

A few examples:

  1. Radiological Big-Data based AI algorithms are under development and evaluation. They support radiologists with computer aided diagnosis (CAD) for pulmonary COVID-19 lesions imaged by CT scanners and ER X-Ray systems.
  2. Teleradiology and PACS systems are used for medical consultation between community hospitals and medical centers.
  3. In the USA, Medicare physicians get a full reimbursement for remote tele-visits (using Skype or phone) with patients, whether they are in lockdown or not.
  4. IBM, Oracle, and the World Health Organization (WHO) created (with others) an open-data hub that will use blockchain technology to check the veracity of data relating to the coronavirus pandemic.
  5. Homecare ICT is used extensively to monitor COVID-19 positive people by their physicians, saving hospital beds and risky and expensive hospitalization  

  (*) Market size is scenario dependent.

According to the July 1, 2020 report update, the cumulative 2020-2024 Global COVID-19 Pandemic Mitigation Products Market* is forecast to reach $1.6–$2.1 trillion.

The COVID-19 Pandemic Mitigation Products Market – 2020-2024 report includes 54 sub-reports including the following eight COVID-19 related ICT sub-report:

  1. AI, Big Data & Deep Learning
  2. Homecare IT
  3. Contact Tracing Systems & Services
  4. E-Health
  5. Blockchain Technologies
  6. PACS (Picture Archiving and Communication System)
  7. Teleradiology
  8. Other ICT (Information and Communication Technology)

This 1020-page 5-volume market mega report is the first and most comprehensive review of the new global COVID-19 Pandemic Mitigation Products & Services market available today. The “COVID-19 Pandemic Mitigation Products Market – 2020-2024” report presents a thorough market analysis of 54 products & services sub-reports, 6 vertical, 4 revenue source, 5 regional and 13 national markets providing in-depth analysis of this newly formed market.

The objective of this report is to provide today’s strategic decision-makers with an expert 360-degree, time-sensitive, detailed view of this interconnected market and provides answers to questions such as:

  • What is the COVID-19 Pandemic Mitigation Products & Services market size and what are the forecasted trends during 2020-2024?
  • What are the most attractive business opportunities?
  • What drives the customers to purchase solutions and services?
  • What are the COVID-19 Mitigation technology & services trends?
  • What is the 212 sub-markets size over the 2020-2024 period?
  • What are the challenges to market penetration & growth?

To adhere to our high standards of research, as nobody can truly forecast the future of this on-going pandemic, we include in the report two scenarios:

  1. Optimistic scenario – assumes (among other things) that mass vaccination will commence by July 2021
  2. Conservative scenario – assumes (among other things) that no mass vaccination will be available until July 2024

With a highly fragmented market we address the “money trail” – each dollar spent in the global COVID-19 Pandemic Mitigation market is analyzed and crosschecked via 5 orthogonal viewpoints:

  • 54 products and services:

o  COVID -19 Vaccines

o  Medical Eye Protection

o  COVID -19 Therapeutic Drugs

o  PPE Sterilization: Systems & Consumables

o  Other COVID-19 Pharma Industry Products

o  Hand & Surface Sanitizers

o  PCR Instrumentation & Software

o  Decontamination

o  Robotic PCR Systems & Software

o  Other Personal Protection Gear

o  PCR Reagents & Consumables

o  AI, Big Data & Deep Learning

o  Nose & Mouth Swabs

o  Homecare IT

o  Self-collection PCR Test Kits

o  Geo-Surveillance Systems & Services

o  Serologic Test Kits

o  E-Health

o  Standoff Thermometry

o  Blockchain Technologies

o  X-Ray Procedures

o  Other ICT

o  CT Procedures

o  Noninvasive Ventilators

o  Ultrasound Procedures

o  Invasive Mechanical Ventilators

o  Wastewater testing

o  Next Generation Ventilators

o  FDG-PET/CT Procedures

o  COVID-19 Waste Water Surveillance

o  COVID-19 Homecare

o  PACS & Teleradiology

o  Portable Ventilators

o  Medical PPE Gowns

o  Surge Capacity Hospitals & ICUs

o  Medical Gloves

o  Kidney Dialysis

o  Medical Face Masks

o  Extracorporeal Membrane Oxygenation Procedures

o  Medical Face Shields

o  Other Intensive Care Modalities

o  PPE Gowns Manufacturing Plants

o  PCR Systems Manufacturing Plants

o  Gloves Manufacturing Plants

o  Nose & Mouth Swabs Manufacturing Plants

o  Face Masks Manufacturing Plants

o  COVID-19 Vaccine Manufacturing Plants

o  Face Shields Manufacturing Plants

o  R&D Equipment & Consumables

o  Self-Collected PCR Test Kits Manufacturing. Plants

o  Medical Glass

o  Melt-Blown PPE Fabric Manufacturing Plants

o  Ventilators Manufacturing Plants

o  Spun-Bond PPE Fabric Manufacturing Plants

o  PCR Reagents Manufacturing Plants

o  Serological Test Kits Manufacturing Plants

  • 6 vertical markets:
    • Hospitals & Surge Hospitals
    • Clinical Labs
    • Clinics
    • Emergency Medical Services (EMS)
    • Homecare & Nursing Homes
    • Research Bodies
  • 13 national markets:
    • USA
    • Canada
    • UK
    • Germany
    • France
    • Italy
    • Rest of Europe
    • India
    • China
    • South Korea
    • Japan
    • Rest of Asia Pacific
    • ROW
  • 5 regional markets:
    • North America
    • Latin America
    • Europe
    • Middle East & Africa
    • Asia Pacific
  • 4 revenue source markets:
    • Product Sales
    • Training Services
    • Planning & Consulting
    • Maintenance & Upgrades

View the comprehensive TOC of this report to browse through 5 volumes of market data, spanning over 1,020 pages, including 728 tables & figures and 212 submarkets – download TOC

For more information, or to purchase a copy, please visit us here.

About the analysts that composed this report:
The team which composed this report brings 43 years of hands on record in the development and commercialization of healthcare products including: antibody antigen detection, E-health, Bio-decontamination and biosecurity, PACS, teleradiology, PPE, computerized tomography, medical devices, and brings long term cooperation with the FDA and CDC as well as the EU CE and other national medical legislation agencies. As early as January 20, 2020 we recruited all our analysts to research the COVID-19 pandemic mitigation related products & services purchases. We interviewed hundreds of experts, participated in more than 95 conferences and webinars, reviewed more than 1,500 publications and interviewed executives of more than 65 pandemic related companies.

About Homeland Security Research Corp. (HSRC)
Homeland Security Research Corp. (HSRC) is an international market and technology research firm specializing in the Public Safety Industry. HSRC provides premium off-the-shelf and customized market reports on present and emerging technologies and industry expertise, enabling global clients to gain time-critical insight into business opportunities. HSRC’s clients include the U.S. Congress, DHS, U.S. Army, U.S. Navy, DOD, DOT, GAO, NATO, and EU, among others, as well as government agencies in Japan, Korea, Taiwan, Israel, Canada, UK, Germany, Australia, Sweden, Finland, Singapore. With over 950 private sector clients (76% returning), including major defense and security contractors and Fortune 2000 companies, HSRC earned the reputation as the industry’s Gold Standard for public safety market reports.

Washington D.C. 20004, 601 Pennsylvania Ave., NW Suite 900,
Tel: 202-455-0966, [email protected]

SOURCE Homeland Security Research Corp. (HSRC)

Related Links